| scholarly article | Q13442814 |
| P50 | author | Jugsharan S. Virdi | Q55743823 |
| P2093 | author name string | Priyanka Bajaj | |
| Nambram S Singh | |||
| P2860 | cites work | In vitro selection of variants resistant to beta-lactams plus beta-lactamase inhibitors in CTX-M beta-lactamases: predicting the in vivo scenario? | Q38626867 |
| Prevalence and characterization of extended-spectrum beta-lactamase (ESBL)- and CMY-2-producing Escherichia coli isolates from healthy food-producing animals in Tunisia. | Q38902617 | ||
| Chromosome-mediated OXA-48 carbapenemase in highly virulent Escherichia coli. | Q39459908 | ||
| Characterization of OXA-25, OXA-26, and OXA-27, molecular class D beta-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii | Q39476331 | ||
| CTX-M-15-non-ST131 Escherichia coli isolates are mainly responsible of faecal carriage with ESBL-producing Enterobacteriaceae in travellers, immigrants and those visiting friends and relatives | Q39546864 | ||
| Novel complex sul1-type integron in Escherichia coli carrying bla(CTX-M-9). | Q39652578 | ||
| Detection of plasmid-mediated AmpC beta-lactamase genes in clinical isolates by using multiplex PCR. | Q39664817 | ||
| Antibiotic resistance of faecal Escherichia coli from healthy volunteers from eight developing countries. | Q39697165 | ||
| Emergence of an inhibitor-resistant beta-lactamase (SHV-10) derived from an SHV-5 variant. | Q39783976 | ||
| Carbapenem-resistant Escherichia coli harboring Klebsiella pneumoniae carbapenemase beta-lactamases associated with long-term care facilities | Q39843388 | ||
| Quinolone co-resistance in ESBL- or AmpC-producing Escherichia coli from an Indian urban aquatic environment and their public health implications | Q40324905 | ||
| Use of ChromID extended-spectrum beta-lactamase medium for detecting carbapenemase-producing Enterobacteriaceae | Q40343571 | ||
| Use of several inducer and substrate antibiotic combinations in a disk approximation assay format to screen for AmpC induction in patient isolates of Pseudomonas aeruginosa, Enterobacter spp., Citrobacter spp., and Serratia spp. | Q40710250 | ||
| ISEcp1B-mediated transposition of blaCTX-M in Escherichia coli | Q40734501 | ||
| Diversity of STs, plasmids and ESBL genes among Escherichia coli from humans, animals and food in Germany, the Netherlands and the UK. | Q40820465 | ||
| Characterization of CTX-M-14-producing Escherichia coli from food-producing animals | Q40925539 | ||
| A novel plasmid carrying blaCTX-M-15 identified in commensal Escherichia coli from healthy pregnant women in Ibadan, Nigeria | Q41460107 | ||
| Substitutions at position 105 in SHV family β-lactamases decrease catalytic efficiency and cause inhibitor resistance | Q41571099 | ||
| Evolutionary potential, cross-stress behavior and the genetic basis of acquired stress resistance in Escherichia coli. | Q41584086 | ||
| Emergence of Escherichia coli producing extended-spectrum AmpC β-lactamases (ESAC) in animals | Q41766424 | ||
| CTX-M-10 linked to a phage-related element is widely disseminated among Enterobacteriaceae in a Spanish hospital | Q41811129 | ||
| Interactions of oximino-substituted boronic acids and β-lactams with the CMY-2-derived extended-spectrum cephalosporinases CMY-30 and CMY-42 | Q41821008 | ||
| Inducible cephalosporinase production in clinical isolates of Enterobacter cloacae is controlled by a regulatory gene that has been deleted from Escherichia coli | Q41882037 | ||
| Multi-centre evaluation of real-time multiplex PCR for detection of carbapenemase genes OXA-48, VIM, IMP, NDM and KPC. | Q41883325 | ||
| Emergence of metallo-β-lactamase NDM-1-producing multidrug-resistant Escherichia coli in Australia | Q42012070 | ||
| Detection of AmpC beta-lactamase in Escherichia coli: comparison of three phenotypic confirmation assays and genetic analysis | Q42016476 | ||
| High prevalence of fecal carriage of extended spectrum β-lactamase/AmpC-producing Enterobacteriaceae in cats and dogs | Q42019900 | ||
| Characteristics of NDM-1-producing Escherichia coli isolates that belong to the successful and virulent clone ST131. | Q42037165 | ||
| Dissemination of clonally related Escherichia coli strains expressing extended-spectrum beta-lactamase CTX-M-15. | Q42111230 | ||
| Spread of bla(CTX-M-14) is driven mainly by IncK plasmids disseminated among Escherichia coli phylogroups A, B1, and D in Spain. | Q42111488 | ||
| Rapid dissemination and diversity of CTX-M extended-spectrum beta-lactamase genes in commensal Escherichia coli isolates from healthy children from low-resource settings in Latin America. | Q42112155 | ||
| Dissemination and persistence of blaCTX-M-9 are linked to class 1 integrons containing CR1 associated with defective transposon derivatives from Tn402 located in early antibiotic resistance plasmids of IncHI2, IncP1-alpha, and IncFI groups | Q42112419 | ||
| Commensal Escherichia coli of healthy humans: a reservoir for antibiotic-resistance determinants | Q42670127 | ||
| NDM-1-producing Escherichia coli in Germany | Q42706276 | ||
| Community Factors in the Development of Antibiotic Resistance | Q22255601 | ||
| Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention | Q24530558 | ||
| Extended-spectrum beta-lactamases: a clinical update | Q24534999 | ||
| Plasmid-determined AmpC-type beta-lactamases | Q24535748 | ||
| Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat | Q24550671 | ||
| Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study | Q24617818 | ||
| Carbapenemases: the versatile beta-lactamases | Q24685034 | ||
| The Problem of Carbapenemase-Producing-Carbapenem-Resistant-Enterobacteriaceae Detection | Q26770418 | ||
| Extraintestinal Pathogenic Escherichia coli, a Common Human Pathogen: Challenges for Vaccine Development and Progress in the Field | Q26786281 | ||
| Identification and screening of carbapenemase-producing Enterobacteriaceae | Q26824816 | ||
| Current trends in culture-based and molecular detection of extended-spectrum-β-lactamase-harboring and carbapenem-resistant Enterobacteriaceae | Q27026063 | ||
| Functional characterization of the antibiotic resistance reservoir in the human microflora | Q28256703 | ||
| Pathogenic Escherichia coli | Q29616738 | ||
| Antibacterial resistance worldwide: causes, challenges and responses | Q29620008 | ||
| Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M. | Q30354148 | ||
| The CTX-M beta-lactamase pandemic. | Q30356558 | ||
| Pandemic lineages of extraintestinal pathogenic Escherichia coli. | Q30361717 | ||
| Carriage of Escherichia coli Producing CTX-M-Type Extended-Spectrum β-Lactamase in Healthy Vietnamese Individuals. | Q30385320 | ||
| Wide dissemination of extended-spectrum β-lactamase-producing Escherichia coli in community residents in the Indochinese peninsula | Q30389643 | ||
| Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain | Q30396308 | ||
| CTX-M Enzymes: Origin and Diffusion | Q30415141 | ||
| Predicting antimicrobial susceptibilities for Escherichia coli and Klebsiella pneumoniae isolates using whole genomic sequence data. | Q30636622 | ||
| Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244. | Q30834224 | ||
| A qPCR and multiplex pyrosequencing assay combined with automated data processing for rapid and unambiguous detection of ESBL-producers Enterobacteriaceae | Q30986331 | ||
| Global incidence of human Shiga toxin-producing Escherichia coli infections and deaths: a systematic review and knowledge synthesis | Q33414737 | ||
| Antimicrobial resistance and integrons of commensal Escherichia coli strains from healthy humans in China | Q33585223 | ||
| Comparison of phenotypic methods for the detection of carbapenem non-susceptible Enterobacteriaceae | Q33656285 | ||
| An evaluation of the Mast D69C AmpC Detection Disc Set for the detection of inducible and derepressed AmpC -lactamases | Q57077397 | ||
| A sensitive and specific phenotypic assay for detection of metallo-β-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin | Q59239379 | ||
| Evaluation of a DNA microarray for the rapid detection of extended-spectrum -lactamases (TEM, SHV and CTX-M), plasmid-mediated cephalosporinases (CMY-2-like, DHA, FOX, ACC-1, ACT/MIR and CMY-1-like/MOX) and carbapenemases (KPC, OXA-48, VIM, IMP and N | Q59269691 | ||
| Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013 | Q61896181 | ||
| Extended-spectrum beta-lactamases | Q69547842 | ||
| Real-time TaqMan PCR for rapid detection and typing of genes encoding CTX-M extended-spectrum beta-lactamases | Q79436347 | ||
| Analysis of risk factors for a high prevalence of extended-spectrum {beta}-lactamase-producing Enterobacteriaceae in asymptomatic individuals in rural Thailand | Q83366212 | ||
| Prevalence of and risk factors associated with faecal carriage of CTX-M β-lactamase-producing Enterobacteriaceae in rural Thai communities | Q83925974 | ||
| Regulation of inducible AmpC beta-lactamase expression among Enterobacteriaceae. | Q33762377 | ||
| Extended-spectrum-beta-lactamase, AmpC, and Carbapenemase issues | Q33769534 | ||
| Characteristics of Escherichia coli sequence type 131 isolates that produce extended-spectrum β-lactamases: global distribution of the H30-Rx sublineage | Q33798233 | ||
| Inhibitor-resistant TEM- and OXA-1-producing Escherichia coli isolates resistant to amoxicillin-clavulanate are more clonal and possess lower virulence gene content than susceptible clinical isolates | Q33798430 | ||
| Horizontal gene transfer in the human gastrointestinal tract: potential spread of antibiotic resistance genes | Q33816815 | ||
| Genomics of rapid adaptation to antibiotics: convergent evolution and scalable sequence amplification | Q33836661 | ||
| Molecular basis of AmpC hyperproduction in clinical isolates of Escherichia coli | Q33976746 | ||
| CTX-M-type extended-spectrum beta-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop | Q33983530 | ||
| Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues | Q34093612 | ||
| Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers | Q34108669 | ||
| Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens | Q34120145 | ||
| NDM-1--a cause for worldwide concern. | Q34154997 | ||
| Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance | Q34163308 | ||
| Detection of NDM-1, VIM-1, KPC, OXA-48, and OXA-162 carbapenemases by matrix-assisted laser desorption ionization-time of flight mass spectrometry | Q34254372 | ||
| Hemorrhagic Colitis Associated with a RareEscherichia coliSerotype | Q34256166 | ||
| Genotyping using whole-genome sequencing is a realistic alternative to surveillance based on phenotypic antimicrobial susceptibility testing | Q34317087 | ||
| Recent advances in understanding enteric pathogenic Escherichia coli. | Q34375210 | ||
| Global incidence of carbapenemase-producing Escherichia coli ST131. | Q34426812 | ||
| Phylogenetic distribution and prevalence of genes encoding class I Integrons and CTX-M-15 extended-spectrum β-lactamases in Escherichia coli isolates from healthy humans in Chandigarh, India | Q34542111 | ||
| Predicting evolutionary potential: in vitro evolution accurately reproduces natural evolution of the tem beta-lactamase | Q34614621 | ||
| Review of assessments of the human health risk associated with the use of antimicrobial agents in agriculture | Q34623876 | ||
| Community acquisition of β-lactamase producing Enterobacteriaceae in neonatal gut. | Q34775030 | ||
| What antimicrobial resistance has taught us about horizontal gene transfer | Q34959188 | ||
| The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria | Q34969565 | ||
| The changing epidemiology of resistance | Q34997021 | ||
| Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes | Q35006613 | ||
| Clinical and molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli causing bacteremia in the Rotterdam Area, Netherlands | Q35065929 | ||
| Laboratory and clinical evaluation of screening agar plates for detection of carbapenem-resistant Enterobacteriaceae from surveillance rectal swabs. | Q35066821 | ||
| Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem | Q35124037 | ||
| Rapid detection of ESBL-producing Enterobacteriaceae in blood cultures | Q35130334 | ||
| A method for the detection of antibiotic resistance markers in clinical strains of Escherichia coli using MALDI mass spectrometry | Q35551420 | ||
| Molecular characterization of a multidrug resistance IncF plasmid from the globally disseminated Escherichia coli ST131 clone | Q35602248 | ||
| Efficient Detection of Carbapenemase Activity in Enterobacteriaceae by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry in Less Than 30 Minutes | Q35618481 | ||
| Avibactam and inhibitor-resistant SHV β-lactamases | Q35746285 | ||
| Plasmids and the spread of resistance | Q38090172 | ||
| Phenotypic detection of carbapenem-susceptible metallo-beta-lactamase-producing gram-negative bacilli in the clinical laboratory | Q38475911 | ||
| Biochemical study of a new inhibitor-resistant beta-lactamase, SHV-84, produced by a clinical Escherichia coli strain. | Q42794452 | ||
| Detection of extended-spectrum beta-lactamases among Enterobacteriaceae by use of semiautomated microbiology systems and manual detection procedures | Q42799124 | ||
| Positive extended-spectrum-beta-lactamase (ESBL) screening results may be due to AmpC beta-lactamases more often than to ESBLs | Q42924543 | ||
| Development of a real-time SYBRGreen PCR assay for rapid detection of acquired AmpC in Enterobacteriaceae | Q42988603 | ||
| Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States | Q43007779 | ||
| Detection of the new metallo-beta-lactamase VIM-19 along with KPC-2, CMY-2 and CTX-M-15 in Klebsiella pneumoniae | Q43045102 | ||
| Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections | Q43108510 | ||
| Detection of OXA-48 carbapenemase in the pandemic clone Escherichia coli O25b:H4-ST131 in the course of investigation of an outbreak of OXA-48-producing Klebsiella pneumoniae | Q43219324 | ||
| Phenotypic and molecular characterization of plasmid mediated AmpC β-lactamases among Escherichia coli, Klebsiella spp., and Proteus mirabilis isolated from urinary tract infections in Egyptian hospitals. | Q43479674 | ||
| Multiple ST clonal complexes, with a predominance of ST131, of Escherichia coli harbouring blaCTX-M-15 in a tertiary hospital in Tanzania | Q43940405 | ||
| Emergence, spread, and environmental effect of antimicrobial resistance: how use of an antimicrobial anywhere can increase resistance to any antimicrobial anywhere else | Q43978865 | ||
| CMY-42, a novel plasmid-mediated CMY-2 variant AmpC beta-lactamase | Q44014490 | ||
| Does broad-spectrum beta-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria? | Q44243558 | ||
| Detection of clinically important β-lactamases in commensal Escherichia coli of human and swine origin in western China | Q44282069 | ||
| Bacteraemia caused by third-generation cephalosporin-resistant Escherichia coli in France: prevalence, molecular epidemiology and clinical features | Q44471729 | ||
| Molecular and clinical characterization of plasmid-mediated AmpC β-lactamase-producing Escherichia coli bacteraemia: a comparison with extended-spectrum β-lactamase-producing and non-resistant E. coli bacteraemia | Q44593757 | ||
| Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. | Q45044150 | ||
| Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway. | Q45956989 | ||
| Disc methods for detecting AmpC {beta}-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae | Q46640829 | ||
| The MAST® D68C test: an interesting tool for detecting extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae. | Q46786889 | ||
| AmpC beta-lactamase-mediated cefpodoxime-resistant Escherichia coli isolated from faecal samples of healthy volunteers | Q46843547 | ||
| Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. | Q46852401 | ||
| Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis | Q46868144 | ||
| Characterization of the highly variable region surrounding the bla(CTX-M-9) gene in non-related Escherichia coli from Barcelona | Q48119358 | ||
| Insertion of IS2 creates a novel ampC promoter in Escherichia coli | Q48399769 | ||
| The E. coli beta-lactamase attenuator mediates growth rate-dependent regulation | Q48410272 | ||
| First description of an oxyimino-cephalosporin-resistant, ESBL-carrying Escherichia coli isolated from meat sold in Denmark. | Q50543171 | ||
| Faecal carriage of extended-spectrum β-lactamase-producing and AmpC β-lactamase-producing bacteria among Danish army recruits. | Q50551815 | ||
| Characterization of third-generation cephalosporin-resistant Escherichia coli from bloodstream infections in Denmark. | Q50560832 | ||
| β LACTA test for rapid detection of Enterobacteriaceae resistant to third-generation cephalosporins from positive blood cultures using briefly incubated solid medium cultures. | Q51795779 | ||
| DNA sequence analysis of the genetic environment of various blaCTX-M genes. | Q52567224 | ||
| AmpC beta-lactamases in Escherichia coli: emergence of CMY-2-producing virulent phylogroup D isolates belonging mainly to STs 57, 115, 354, 393, and 420, and phylogroup B2 isolates belonging to the international clone O25b-ST131. | Q53174362 | ||
| Plasmid-mediated carbapenem and colistin resistance in a clinical isolate of Escherichia coli. | Q53801451 | ||
| Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyiminocephalosporins without extended spectrum beta-lactamase production. | Q54097603 | ||
| Demystifying Escherichia coli pathovars. | Q54277052 | ||
| A new plasmidic cefotaximase in a clinical isolate of Escherichia coli. | Q54316090 | ||
| Rapid emergence and spread of OXA-48-producing carbapenem-resistant Enterobacteriaceae isolates in Belgian hospitals. | Q54337305 | ||
| Prevalence and characterisation of CTX-M β-lactamases amongst Escherichia coli isolates from healthy food animals in China. | Q54342537 | ||
| Comparative epidemiology of CTX-M-14 and CTX-M-15 producing Escherichia coli: association with distinct demographic groups in the community in New Zealand. | Q54343678 | ||
| Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases. | Q54359438 | ||
| In vitro efficiency of the piperacillin/tazobactam combination against inhibitor-resistant TEM- and complex mutant TEM-producing clinical strains of Escherichia coli. | Q54365696 | ||
| Emergence of clonal groups O1:HNM-D-ST59, O15:H1-D-ST393, O20:H34/HNM-D-ST354, O25b:H4-B2-ST131 and ONT:H21,42-B1-ST101 among CTX-M-14-producing Escherichia coli clinical isolates in Galicia, northwest Spain. | Q54375846 | ||
| Broad-spectrum, transmissible beta-lactamases. | Q54376597 | ||
| Extended broad-spectrum beta-lactamases conferring transferable resistance to newer beta-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. | Q54380570 | ||
| Multiplex PCR for detection of acquired carbapenemase genes. | Q54383399 | ||
| Characterisation of clinical and food animal Escherichia coli isolates producing CTX-M-15 extended-spectrum β-lactamase belonging to ST410 phylogroup A. | Q54387198 | ||
| Extended-spectrum beta-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and ST131/B2. | Q54404451 | ||
| Faecal carriage of extended-spectrum beta-lactamase-producing Escherichia coli: prevalence, risk factors and molecular epidemiology. | Q54419391 | ||
| Most Escherichia coli strains overproducing chromosomal AmpC beta-lactamase belong to phylogenetic group A. | Q54437235 | ||
| Recent Emergence of Escherichia coli with Cephalosporin Resistance Conferred by blaCTX-M on Washington State Dairy Farms | Q35764110 | ||
| Molecular identification of extended-spectrum-β-lactamase genes from Enterobacteriaceae isolated from healthy human carriers in Switzerland | Q35806418 | ||
| Global spread of Carbapenemase-producing Enterobacteriaceae | Q35847641 | ||
| Resistance to broad-spectrum antibiotics in aquatic systems: anthropogenic activities modulate the dissemination of bla(CTX-M)-like genes. | Q36017993 | ||
| Comparative evaluation of a prototype chromogenic medium (ChromID CARBA) for detecting carbapenemase-producing Enterobacteriaceae in surveillance rectal swabs | Q36022864 | ||
| Spanish multicenter study of the epidemiology and mechanisms of amoxicillin-clavulanate resistance in Escherichia coli | Q36086480 | ||
| Pathogenic Escherichia coli producing Extended-Spectrum β-Lactamases isolated from surface water and wastewater | Q36099804 | ||
| The role of horizontal gene transfer in the dissemination of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in an endemic setting. | Q36188141 | ||
| Rapid detection of carbapenemase-producing Enterobacteriaceae | Q36221193 | ||
| Clonal structure, extended-spectrum β-lactamases, and acquired AmpC-type cephalosporinases of Escherichia coli populations colonizing patients in rehabilitation centers in four countries | Q36505381 | ||
| CMY-13, a novel inducible cephalosporinase encoded by an Escherichia coli plasmid. | Q36670970 | ||
| First Characterization of CTX-M-15-Producing Escherichia coli Strains Belonging to Sequence Type (ST) 410, ST224, and ST1284 from Commercial Swine in South America | Q36730162 | ||
| Commensal Enterobacteriaceae as reservoirs of extended-spectrum beta-lactamases, integrons, and sul genes in Portugal | Q36748262 | ||
| High rate of intestinal colonization with extended-spectrum-beta-lactamase-producing organisms in household contacts of infected community patients | Q36845508 | ||
| IRT and CMT beta-lactamases and inhibitor resistance | Q37043593 | ||
| Phenotypic detection of extended-spectrum beta-lactamase production in Enterobacteriaceae: review and bench guide. | Q37043607 | ||
| Capturing the mutational landscape of the beta-lactamase TEM-1. | Q37088726 | ||
| Identification of plasmid-mediated AmpC beta-lactamases in Escherichia coli, Klebsiella spp., and proteus species can potentially improve reporting of cephalosporin susceptibility testing results | Q37099549 | ||
| Epidemic clonal groups of Escherichia coli as a cause of antimicrobial-resistant urinary tract infections in Canada, 2002 to 2004 | Q37247793 | ||
| Clinical features and molecular epidemiology of CMY-type beta-lactamase-producing Escherichia coli. | Q37263601 | ||
| Four main virotypes among extended-spectrum-β-lactamase-producing isolates of Escherichia coli O25b:H4-B2-ST131: bacterial, epidemiological, and clinical characteristics. | Q37264353 | ||
| AmpC beta-lactamases | Q37366249 | ||
| The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx | Q37408471 | ||
| Extended-spectrum-β-lactamase-producing Escherichia coli as intestinal colonizers in the German community | Q37544824 | ||
| Detection of resistance to beta-lactamase inhibitors in strains with CTX-M beta-lactamases: a multicenter external proficiency study using a well-defined collection of Escherichia coli strains. | Q37546694 | ||
| Has the era of untreatable infections arrived? | Q37578902 | ||
| Molecular and kinetic comparison of the novel extended-spectrum beta-lactamases CTX-M-25 and CTX-M-26. | Q37624427 | ||
| Infections with extended-spectrum beta-lactamase-producing enterobacteriaceae: changing epidemiology and drug treatment choices | Q37694529 | ||
| Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae | Q37797732 | ||
| The CTX-M conundrum: dissemination of plasmids and Escherichia coli clones | Q37833633 | ||
| Co-resistance: an opportunity for the bacteria and resistance genes | Q37917155 | ||
| Extended-spectrum β-lactamase-producing and AmpC-producing Escherichia coli from livestock and companion animals, and their putative impact on public health: a global perspective. | Q38004083 | ||
| The role of the natural environment in the emergence of antibiotic resistance in gram-negative bacteria | Q38076545 | ||
| Urban wastewater treatment plants as hotspots for antibiotic resistant bacteria and genes spread into the environment: a review. | Q38080393 | ||
| CTX-M-type β-lactamases: a successful story of antibiotic resistance | Q38089423 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Escherichia coli | Q25419 |
| P304 | page(s) | 417 | |
| P577 | publication date | 2016-01-01 | |
| P1433 | published in | Frontiers in Microbiology | Q27723481 |
| P1476 | title | Escherichia coli β-Lactamases: What Really Matters | |
| P478 | volume | 7 |
| Q91788081 | An overview of the antimicrobial resistance mechanisms of bacteria |
| Q64057965 | Anesthesia and surgery induce cognitive dysfunction in elderly male mice: the role of gut microbiota |
| Q31152845 | Antibiotic resistance patterns of Escherichia coli urinary isolates and comparison with antibiotic consumption data over 10 years, 2005-2014. |
| Q92855067 | ESBL and AmpC β-Lactamases in Clinical Strains of Escherichia coli from Serra da Estrela, Portugal |
| Q90431209 | Extended-spectrum β-lactamase prevalence and virulence factor characterization of enterotoxigenic Escherichia coli responsible for acute diarrhea in Nepal from 2001 to 2016 |
| Q28354075 | First Report of Group CTX-M-9 Extended Spectrum Beta-Lactamases in Escherichia coli Isolates from Pediatric Patients in Mexico |
| Q89186453 | Genetic analysis of invasive Escherichia coli in Scotland reveals determinants of healthcare-associated versus community-acquired infections |
| Q89972130 | Machine learning with random subspace ensembles identifies antimicrobial resistance determinants from pan-genomes of three pathogens |
| Q101226482 | Plasmid- and strain-specific factors drive variation in ESBL-plasmid spread in vitro and in vivo |
| Q96303530 | Prediction of Antimicrobial Resistance in Gram-Negative Bacteria From Whole-Genome Sequencing Data |
| Q40176262 | Targeting the gram-negative bacteria peptidoglycan synthase MraY as a new approach for monoclonal antibody anti-bacterial activity |
| Q64059540 | Transcriptome analysis of beta-lactamase genes in diarrheagenic Escherichia coli |
| Q64059475 | Two Component Regulatory Systems and Antibiotic Resistance in Gram-Negative Pathogens |
Search more.